GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » 5-Year Yield-on-Cost %

West Pharmaceutical Services (BSP:W2ST34) 5-Year Yield-on-Cost % : 0.20 (As of Apr. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services 5-Year Yield-on-Cost %?

West Pharmaceutical Services's yield on cost for the quarter that ended in Mar. 2024 was 0.20.


The historical rank and industry rank for West Pharmaceutical Services's 5-Year Yield-on-Cost % or its related term are showing as below:

BSP:W2ST34' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.19   Med: 0.7   Max: 1.55
Current: 0.2


During the past 13 years, West Pharmaceutical Services's highest Yield on Cost was 1.55. The lowest was 0.19. And the median was 0.70.


BSP:W2ST34's 5-Year Yield-on-Cost % is ranked worse than
94.21% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs BSP:W2ST34: 0.20

Competitive Comparison of West Pharmaceutical Services's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's 5-Year Yield-on-Cost % falls into.



West Pharmaceutical Services 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of West Pharmaceutical Services is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

West Pharmaceutical Services  (BSP:W2ST34) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


West Pharmaceutical Services 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services (BSP:W2ST34) Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (BSP:W2ST34) Headlines

No Headlines